Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
Authors
Keywords
Bi-specific TCR, ImmTAC, Cancer immunotherapy, NY-ESO-1, LAGE-1, Time-domain
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 62, Issue 4, Pages 773-785
Publisher
Springer Nature
Online
2012-12-21
DOI
10.1007/s00262-012-1384-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Plasma Colloid Osmotic Pressure Facilitates the Uptake of Therapeutic Macromolecules in a Xenograft Tumor Model
- (2015) Matthias Hofmann et al. NEOPLASIA
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- In Vivo Fluorescence Lifetime Imaging Monitors Binding of Specific Probes to Cancer Biomarkers
- (2012) Yasaman Ardeshirpour et al. PLoS One
- Minimally invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin
- (2011) Tine V. Karlsen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma
- (2010) Cyril Cuffel et al. INTERNATIONAL JOURNAL OF CANCER
- Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors
- (2009) S. Bobisse et al. CANCER RESEARCH
- Bispecific T-Cell Engaging Antibodies for Cancer Therapy
- (2009) P. A. Baeuerle et al. CANCER RESEARCH
- Cancer/testis (CT) antigens: Potential targets for immunotherapy
- (2009) Otavia L. Caballero et al. CANCER SCIENCE
- Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire
- (2009) G. Bioley et al. CLINICAL CANCER RESEARCH
- The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
- (2009) M. Galgani et al. CURRENT MEDICINAL CHEMISTRY
- Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab
- (2009) Dirk Nagorsen et al. LEUKEMIA & LYMPHOMA
- Imaging in the era of molecular oncology
- (2008) Ralph Weissleder et al. NATURE
- Molecular imaging in drug development
- (2008) Jürgen K. Willmann et al. NATURE REVIEWS DRUG DISCOVERY
- Positive and negative influences of regulatory T cells on tumour immunity
- (2008) A M Gallimore et al. ONCOGENE
- Genome-wide analysis of cancer/testis gene expression
- (2008) O. Hofmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started